Recruiting nowN/AAges 18 Years and up
Phase II Study of 5-Day Hypofractionated Preoperative Radiation Therapy for Soft Tissue Sarcomas: Expansion Cohort
Sponsor: Jonsson Comprehensive Cancer Center · NCT02701153 on ClinicalTrials.gov ↗
Conditions studied
Recurrent Adult Soft Tissue Sarcoma
What it tests
- Conventional Surgeryprocedure
- Hypofractionated Radiation Therapyradiation
- Laboratory Biomarker Analysisother
- Questionnaire Administrationother
Where it's running1 site
- Recruiting now
UCLA / Jonsson Comprehensive Cancer Center
Los Angeles, California 90095
- Vincent Basehart(contact)310-267-8954[email protected]
- Anusa Kalbasi, M.D.(principal investigator)
See the official eligibility language
Shown exactly as written on ClinicalTrials.gov. Your oncologist is the right person to judge whether it fits your situation.
Inclusion Criteria: * Histologically confirmed soft tissue sarcoma of the extremity/trunk * Intermediate or high grade sarcoma * Resectable primary lesion (patients with pre-existing metastasis will be included if their primary is still going to be resected) * Recurrent, any grade, no previous radiation therapy * Karnofsky performance status (KPS) \>= 70 or Eastern Cooperative Oncology Group (ECOG) 0 - 2 * If a woman is of childbearing potential, a negative serum pregnancy test must be documented Exclusion Criteria: * Active treatment of a separate malignancy * History of prior irradiation to the area to be treated * Pre-operative chemotherapy (post-op acceptable)
Updated 2026-03-10 on ClinicalTrials.gov. Always confirm current details with the study team or your oncologist.